Cite
HARVARD Citation
Li, D. et al. (2018). Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES. Alimentary pharmacology & therapeutics. 47 (2), pp. 246-258. [Online].